Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 10701-10750 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05000840
Integrating Abbott Point-of-Care Technologies and the Community Scientist Model to Support HbA1c Testing Per ADA
N/AActive, not recruiting
750 participants
Started: Oct 20, 2021 · Completed: Mar 31, 2025
2 conditions3 sponsors1 location
NCT05044897
A Clinical Study to Evaluate the Efficacy and Safety of SI-B001 in the Treatment of Recurrent and Metastatic HNSCC
PHASE2Active, not recruiting
11 participants
Started: Oct 20, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT05121519
Does Eliminating Coffee Avoid Fibrillation?
NAActive, not recruiting
200 participants
Started: Oct 20, 2021 · Completed: Oct 20, 2025
2 conditions1 sponsor3 locations
NCT05118828
Guided Internet-based Interventions in Primary Care Effectiveness-implementation Randomized Controlled Trial
NAActive, not recruiting
1,000 participants
Started: Oct 20, 2021 · Completed: Jun 30, 2026
2 conditions6 sponsors6 locations
NCT05974826
Healthy Communities: a Healthy City Preventive Program on Cardiovascular Health and Well-being (HC)
NAActive, not recruiting
2,000 participants
Started: Oct 20, 2021 · Completed: Dec 31, 2030
3 conditions3 sponsors1 location
NCT04927689
Evaluation of an Environmental Counsellor's Home Stay in Children Treated for Asthma or Allergic Rhinitis Via a Standardized Medical Questionnaire Randomized Controlled Superiority Trial in Parallel Arms, Multicentric (EvalPCE)
N/AActive, not recruiting
100 participants
Started: Oct 20, 2021 · Completed: Jan 15, 2026
1 condition1 sponsor1 location
NCT05500846
Targeted Cryoablation of Prostate Cancer Lesions: An Investigator-initiated Trial
NAActive, not recruiting
51 participants
Started: Oct 19, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor2 locations
NCT05516810
The Accuracy of Ultrasound Diagnosis of Hydatidiform Moles
N/AActive, not recruiting
500 participants
Started: Oct 19, 2021 · Completed: Sep 30, 2024
5 conditions2 sponsors2 locations
NCT04546620
Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL)
PHASE2Active, not recruiting
453 participants
Started: Oct 19, 2021 · Completed: May 31, 2028
1 condition2 sponsors33 locations
NCT05062031
Myopia Control in Children: Comparison of Defocus Incorporated Multiple Segments® Lenses Versus Atropine 0.05% Eyedrops
NAActive, not recruiting
242 participants
Started: Oct 19, 2021 · Completed: Feb 28, 2026
1 condition3 sponsors1 location
NCT04986566
Perioperative Telemonitoring to Optimize Cancer Care and Outcomes
NAActive, not recruiting
134 participants
Started: Oct 19, 2021 · Completed: Feb 7, 2026
1 condition3 sponsors1 location
NCT05044546
A Behavioral Activation Prenatal and Postpartum Intervention for Depressed Pregnant Smokers
NAActive, not recruiting
26 participants
Started: Oct 19, 2021 · Completed: Mar 31, 2026
2 conditions5 sponsors1 location
NCT04668001
Transcranial Photobiomodulation With Near-Infrared Light for Language in Individuals With Down Syndrome
NAActive, not recruiting
19 participants
Started: Oct 19, 2021 · Completed: Sep 1, 2024
1 condition1 sponsor1 location
NCT03865160
Low-dose Atropine for Myopia Control in Children
PHASE2/PHASE3Active, not recruiting
302 participants
Started: Oct 19, 2021 · Completed: Nov 30, 2027
1 condition1 sponsor19 locations
NCT04809376
Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain
PHASE2/PHASE3Active, not recruiting
602 participants
Started: Oct 19, 2021 · Completed: Jan 6, 2025
1 condition1 sponsor33 locations
NCT05066997
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)
PHASE2/PHASE3Active, not recruiting
552 participants
Started: Oct 19, 2021 · Completed: Apr 30, 2026
1 condition1 sponsor52 locations
NCT05100472
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
PHASE2Active, not recruiting
50 participants
Started: Oct 19, 2021 · Completed: Oct 19, 2025
1 condition1 sponsor7 locations
NCT04584320
Identification of Clostridium Butyricum and Clostridium Neonatal in the Digestive Microbiota of Premature Infants Before 34 Weeks and Developing or Not Ulcerative Necrotizing Enterocolitis (NEC) During Hospitalization
N/AActive, not recruiting
40 participants
Started: Oct 18, 2021 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05057182
Third Dose of mRNA Vaccination to Boost COVID-19 Immunity (mBoost Study)
PHASE4Active, not recruiting
300 participants
Started: Oct 18, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05104866
A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)
PHASE3Active, not recruiting
732 participants
Started: Oct 18, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors167 locations
NCT04795661
Immunotherapy in MSI/dMMR Tumors in Perioperative Setting.
PHASE2Active, not recruiting
240 participants
Started: Oct 18, 2021 · Completed: Oct 31, 2029
2 conditions1 sponsor17 locations
NCT05081492
CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer
PHASE1Active, not recruiting
9 participants
Started: Oct 18, 2021 · Completed: Mar 30, 2026
3 conditions3 sponsors1 location
NCT05577000
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
PHASE1Active, not recruiting
5 participants
Started: Oct 18, 2021 · Completed: Oct 1, 2043
2 conditions4 sponsors1 location
NCT05092542
Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers
NAActive, not recruiting
1,212 participants
Started: Oct 18, 2021 · Completed: Jul 31, 2026
4 conditions2 sponsors1 location
NCT04961762
Navigator Program for Homeless Adults
NAActive, not recruiting
656 participants
Started: Oct 18, 2021 · Completed: Aug 1, 2025
4 conditions2 sponsors1 location
NCT04673448
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer
PHASE1Active, not recruiting
18 participants
Started: Oct 18, 2021 · Completed: Sep 30, 2026
27 conditions2 sponsors1 location
NCT05065008
The Roles of Gut Microbiome in UTI Susceptible Women
NAActive, not recruiting
160 participants
Started: Oct 18, 2021 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT05162755
S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers
PHASE1Active, not recruiting
51 participants
Started: Oct 15, 2021 · Completed: Jun 19, 2025
1 condition2 sponsors5 locations
NCT04708418
A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma
PHASE2Active, not recruiting
60 participants
Started: Oct 15, 2021 · Completed: Jun 30, 2026
6 conditions1 sponsor188 locations
NCT04806061
Urine Alkalinisation in COVID-19
NAActive, not recruiting
80 participants
Started: Oct 15, 2021 · Completed: Jul 30, 2024
2 conditions2 sponsors2 locations
NCT05123144
A Hybrid Type II Trial of the Optimizing Resilience and Coping With HIV Through Internet Delivery in Ryan White Clinics in Chicago
PHASE2Active, not recruiting
300 participants
Started: Oct 15, 2021 · Completed: Dec 31, 2025
1 condition3 sponsors3 locations
NCT04811287
PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome
NAActive, not recruiting
46 participants
Started: Oct 15, 2021 · Completed: Dec 28, 2026
2 conditions1 sponsor1 location
NCT05422742
Influence of SRP With MM on the Composition and Functional Characteristics of Subgingival Microbiome Communities
NAActive, not recruiting
50 participants
Started: Oct 15, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05158322
Effectiveness of the Decolonization Circuit of S. Aureus, Reducing Infection in Primary Arthroplasty of the Lower Limb
N/AActive, not recruiting
90 participants
Started: Oct 14, 2021 · Completed: May 30, 2025
3 conditions1 sponsor1 location
NCT05069974
Alternative Antibiotics for Syphilis
PHASE3Active, not recruiting
224 participants
Started: Oct 14, 2021 · Completed: Apr 30, 2026
3 conditions1 sponsor6 locations
NCT04662879
Early Detection Initiative for Pancreatic Cancer
NAActive, not recruiting
8,869 participants
Started: Oct 14, 2021 · Completed: Jan 31, 2028
3 conditions1 sponsor2 locations
NCT05059262
Study of Vimseltinib for Tenosynovial Giant Cell Tumor
PHASE3Active, not recruiting
123 participants
Started: Oct 14, 2021 · Completed: Jul 31, 2026
5 conditions1 sponsor35 locations
NCT04848038
Combined Exercise Trial
NAActive, not recruiting
280 participants
Started: Oct 14, 2021 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05057247
Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC
PHASE2Active, not recruiting
26 participants
Started: Oct 14, 2021 · Completed: Jan 1, 2026
5 conditions2 sponsors1 location
NCT04455750
A Clinical Study Evaluating the Benefit of Adding Rucaparib to Enzalutamide for Men with Metastatic Prostate Cancer That Has Become Resistant to Testosterone-Deprivation Therapy
PHASE3Active, not recruiting
61 participants
Started: Oct 14, 2021 · Completed: Sep 30, 2027
5 conditions2 sponsors414 locations
NCT06750471
Dupixent Study for Alternate Administration
PHASE4Active, not recruiting
30 participants
Started: Oct 14, 2021 · Completed: Dec 31, 2025
3 conditions4 sponsors1 location
NCT06522139
Clinical Outcome After Episealer Talus Implant in Treatment of Osteochondral Lesion of the Talus
NAActive, not recruiting
20 participants
Started: Oct 14, 2021 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT05074160
OCS Liver Perfusion (OLP) Post-Approval Registry
N/AActive, not recruiting
166 participants
Started: Oct 14, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor9 locations
NCT05083169
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma
PHASE3Active, not recruiting
587 participants
Started: Oct 14, 2021 · Completed: Dec 8, 2028
1 condition1 sponsor174 locations
NCT04656210
Myotonic Dystrophy - Vascular and Cognition
N/AActive, not recruiting
85 participants
Started: Oct 14, 2021 · Completed: Jan 31, 2029
3 conditions1 sponsor1 location
NCT05030506
A Study of Belzutifan (MK-6482) as Monotherapy and in Combination With Lenvatinib (E7080/MK-7902) With or Without Pembrolizumab (MK-3475) in China Participants With Advanced Renal Cell Carcinoma (MK-6482-010)
PHASE1Active, not recruiting
45 participants
Started: Oct 13, 2021 · Completed: Oct 21, 2026
1 condition1 sponsor5 locations
NCT04274426
Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer
PHASE2Active, not recruiting
136 participants
Started: Oct 13, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor19 locations
NCT04948333
Asciminib Treatment Optimization in ≥ 3rd Line CML-CP
PHASE3Active, not recruiting
199 participants
Started: Oct 13, 2021 · Completed: Feb 3, 2026
1 condition1 sponsor48 locations
NCT04923035
Paediatric Pneumococcal Pneumonia in Malaysia Prior to and During Pneumococcal Conjugate Vaccine (PCV) Implementation
N/AActive, not recruiting
1,010 participants
Started: Oct 13, 2021 · Completed: Dec 31, 2024
2 conditions6 sponsors3 locations
NCT05025800
ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma
PHASE1/PHASE2Active, not recruiting
47 participants
Started: Oct 13, 2021 · Completed: Mar 10, 2026
20 conditions1 sponsor1 location